Clinical pharmacology of antimicrobials for urinary tract infections in newborns and young infants

Journal of Chemotherapy

Volumn 18, Issue C. R. 3, 2006, Pages 14-15

  Aranda, J V ^a   Cataldi, L ^b   Fanos, V ^c  

^a CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

^b CATHOLIC UNIVERSITY   (Italy)

^c UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; CEFEPIME; CEFOTAXIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; COTRIMOXAZOLE; GENTAMICIN;

CLINICAL TRIAL; CONFERENCE PAPER; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG MECHANISM; DRUG TOLERANCE; ENTEROBACTER; ENTEROCOCCUS; HUMAN; KLEBSIELLA; META ANALYSIS; PSEUDOMONAS AERUGINOSA; RECURRENT DISEASE; RENOVASCULAR HYPERTENSION; SEPTICEMIA; SYSTEMATIC REVIEW; URINARY TRACT DISEASE; URINARY TRACT INFECTION; URINE CULTURE;

EID: 33745047113     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1080/1120009x.2006.11782421     Document Type: Conference Paper

References (18)

1. American Academy of Pediatrics. Committee on Quality Improvement. Subcommittee on Urinary Tract Infection. Practice parameter: the diagnosis, treatment, and evaluation of the initial urinary tract infection in febrile infants and young children. Pediatrics. 1999;103(4 Pt 1):843-52. Erratum in: 2000;105(1 Pt 1):141.
2. Pediatrics. 1999;103(5 Pt 1):1052,
3. Pediatrics. 1999;104(1 Pt 1):118.
4. Marild S, Jodal U. Incidence rate of first-time symptomatic urinary tract infection in children under 6 years of age. Acta Paediatr. 1998;87(5):549-52.
5. Aranda JV, Cohen S, Neims AH. Drug utilization in a newborn intensive care unit. J Pediatr. 1976;89(2):315-7.
6. Panaretto K, Craig J, Night J, Howman-Giles R, Sureshkumar P, Roy L. Risk factors for recurrent urinary tract infection in preschool children. J Paediatr Child Health. 1999;35(5):454-9.
7. Kearns GL, Young RA. Pharmacokinetics of cefotaxime and desacetylcefotaxime in the young. Diagn Microbiol Infect Dis. 1995;22(1-2):97-104.
8. Kearns GL, Young RA, Jacobs RF. Cefotaxime dosage in infants and children. Pharmacokinetic and clinical rationale for an extended dosage interval. Clin Pharmacokinet 1992;22(4):284-97.
9. Kearns GL, Jacobs RF, Thomas BR, Darville TL, Trang JM. Cefotaxime and desacetylcefotaxime pharmacokinetics in very low birth weight neonates. J Pediatr. 1989;114(3):461-7.
10. Capparelli E, Hochwald C, Rasmussen M, Parham A, Bradley J, Moya F. Population pharmacokinetics of cefepime in the neonate. Antimicrob Agents Chemother. 2005;49(7):2760-6.
11. Hoberman A, Wald ER, Hickey RW, et al. Oral versus initial intravenous therapy for urinary tract infections in young febrile children. Pediatrics. 1999;104(1 Pt 1):79-8.
12. Baker PC, Nelson DS, Schunk JE. The addition of ceftriaxone to oral therapy does not improve outcome in febrile children with urinary tract infections. Arch Pediatr Adolesc Med. 2001;155(2):135-9.
13. Dayan PS, Hanson E, Bennett JE, Langsam D, Miller SZ. Clinical course of urinary tract infections in infants younger than 60 days of age. Pediatr Emerg Care. 2004;20(2):85-8.
14. Gaspari RJ, Dickson E, Karlowsky J, Doern G. Antibiotic resistance trends in paediatric uropathogens. Int J Antimicrob Agents. 2005;26(4):267-71.
15. Fanos V, Khoory BJ. Antimicrobial survey of urinary tract isolates from a pediatric department. J Chemother. 1999;11(4):255-9.
16. Keren R, Chan E. A meta-analysis of randomized, controlled trials comparing short- and long-course antibiotic therapy for urinary tract infections in children. Pediatrics. 2002;109(5):E70-0.
17. Wheeler D, Vimalachandra D, Hodson EM, et al. Antibiotics and surgery for vesicoureteric reflux: a meta-analysis of randomised controlled trials. Arch Dis Child. 2003;88(8):688-94.
18. Williams GJ, Lee A, Craig JC. Long-term antibiotics for preventing recurrent urinary tract infection in children. Cochrane Database Syst Rev. 2001;(4):CD001534.